Sp275
BACTERIAL METABOLISM AND INTESTINAL DRUG ABSORPTION
Date
May 6, 2023
Explore related products in the following collection:
Tracks
Related Products
AGA Recent Advances in Understanding, Controlling and Treating Enteric Infections
Infectious diarrhea is a leading cause of morbidity and of mortality globally. Enteric pathogens that are the cause of most severe acute diarrhea — as assessed by mortality — include Vibrio cholerae, Shigella spp., Salmonella spp., enteropathogenic E. coli(EPEC), and EAEC…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…